- Published at
- by gurufocus.com
positive
positive
Quest PharmaTech Provides Corporate Update
EDMONTON, Alberta, June 02, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (”Quest” or the ”Company”), a Canadian based pharmaceutical co
News for Quest PharmaTech Inc. (QPTFF)
- Published at
- by manilatimes.net
positivepositive- Published at
- by financialpost.com
neutralneutralQuest PharmaTech Announces Results from AGM
EDMONTON, Alberta, Oct. 11, 2024 (GLOBE NEWSWIRE) — Quest PharmaTech Inc. (TSX-V:QPT) (“Quest” or the “Company”) today announced the results of its October 8, 202…- Published at
- by globenewswire.com
neutralneutralAt 24.8% CAGR, Photodynamic Therapy Devices Market Size Projected to Touch USD 15.8 Billion by 2034: Prophecy Market Insights
“Photodynamic Therapy Devices Market” from 2024-2034 with covered segments By Product Type (Photosensitizer Drugs, Aminolevulinic Acid, Porphyrin...- Published at
- by marketscreener.com
neutralneutralQuest PharmaTech Inc. Receives Recommendations from the Data Safety Monitoring Board to Discontinue Oregovomab Phase III Clinical Study
Quest PharmaTech Inc. announced that it has received information that the Phase III clinical trial of oregovomab for the treatment of Ovarian Cancer, sponsored by CanariaBio Inc. , has received...- Published at
- by globenewswire.com
mixedmixedPhotodynamic Therapy Market Set to Hit USD 5.53 Billion by 2033 | Boosting Opportunities for Medical Innovations
One of the primary growth drivers for the PDT market is the rising incidence of cancer and skin diseases globally. PDT is particularly effective in...- Published at
- by prnewswire.com
mixedmixedPhotodynamic Therapy Market to Amplify Substantially by 2029- Brandessence Market Research
/PRNewswire/ -- According to a comprehensive research report by Brandessence Market Research (BMRC), "Photodynamic Therapy Market Overview, Component, Industry...- Published at
- by globenewswire.com
positivepositivePhotodynamic Therapy Market to Grow at a CAGR of 13.5% from 2022 to 2031, reaching US$ 15.5 Billion: As per TMR Study
Emerging applications in ophthalmology is a major factor that is anticipated to escalate the photodynamic therapy market growth...- Published at
- by marketscreener.com
mixedmixedAurora Cannabis : A MESSAGE FROM OUR CHIEF EXECUTIVE OFFICER - Form 6-K
A MESSAGE FROM OUR CHIEF EXECUTIVE OFFICER September 30, 2022 Fellow shareholders, We are pleased to invite you to... | October 5, 2022- Published at
- by globenewswire.com
mixedmixedPhotodynamic Therapy Market size worth $ 2,308.17 Million, Globally, by 2028 at 8.74% CAGR: Verified Market Research®
An increase in the prevalence of various skin diseases, such as psoriasis, actinic keratosis, acne, rosacea, and others is leading to the growth of the...- Published at
- by markets.businessinsider.com
positivepositiveQuest PharmaTech Announces Results from AGM
TSX Venture: QPT EDMONTON, AB, July 7, 2021 /CNW/ - Quest PharmaTech Inc. (TSX-V: QPT) ('Quest' or the 'Company') today announced the results of ...- Published at
- by prnewswire.com
neutralneutralQuest PharmaTech announces two presentations by OncoQuest Pharmaceuticals, Inc. at the 2021 Annual Meeting of the American Association of Clinical Oncologists
/PRNewswire/ - Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") announces that clinical investigators working with OncoQuest Pharmaceuticals, Inc....- Published at
- by thestreet.com
mixedmixedQuest PharmaTech Announces Two Presentations By OncoQuest Pharmaceuticals, Inc. At The 2021 Annual Meeting Of The American Association Of Clinical Oncologists
TSX Venture: QPT EDMONTON, AB, June 1, 2021 /PRNewswire/ - Quest PharmaTech Inc. (TSXV:- Published at
- by markets.businessinsider.com
positivepositiveQuest Provides Update to Immunotherapy Asset Transfer Between OncoQuest Inc. and OncoQuest Pharmaceuticals Inc.
TSX Venture: QPTEDMONTON, AB, Jan. 5, 2021 /CNW/ - Quest PharmaTech Inc. (TSXV: QPT) ('Quest') provides update to its June 4, 2020 news release to...